Hewlett-Packard Enterprise is set to exit the containerised application security provider in a purchase of undisclosed size by Red Hat.

Cambrian Biopharma returned to back the immunotherapy developer's series B round, following its series A three months ago.

ADM Ventures, GV and Barclays helped the microbe-based protein developer close a round that will support research and development.

Rich Products Ventures has helped the meal delivery service secure $10.3m to hike its overall funding to $26m.

Life sciences veteran Gerald J Vardzel has been named president and CEO of University of Pittsburgh’s LifeX Labs.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GV and Nextech contributed to a series B round that boosted the affordable pharmaceutical developer's overall funding to $750m.

Microsoft, PayU and Boston Consulting Group are among the investors in digital currency platform developer Bakkt, which will list in a reverse merger set to value it at $2.1bn.

Lilly Asia Ventures, a regional corporate venturing subsidiary of pharmaceutical firm Eli Lilly, reinvested in a round set to accelerate development of Abbisko's cancer-focused drug candidates.

BHP Ventures is co-leading the steel manufacturing technology developer's series B round, which has a $60m target for its close.